Bone marrow mesenchymal stem cells preconditioned with nitric-oxide-releasing chitosan/PVA hydrogel accelerate diabetic wound healing in rabbits
- 1 March 2021
- journal article
- research article
- Published by IOP Publishing in Biomedical Materials
- Vol. 16 (3) , 035014
Abstract
Impaired diabetic wounds are one of the major pathophysiological complications caused by persistent microbial infections, prolonged inflammation, and insufficient angiogenic responses. Here, we report the development of nitric-oxide (NO) -releasing S-nitroso-N-acetyl-penicillamine (SNAP) -loaded chitosan/polyvinyl–alcohol hydrogel and its efficacy in enhancing the wound-healing potential of bone marrow mesenchymal stem cells in diabetic wounds. NO-releasing hydrogels significantly increased the cell viability and cell proliferation of hydrogen-peroxide (H 2 O 2 ) -pretreated bone marrow stem cells (BMSCs), demonstrating their cytoprotective activity, which was further confirmed by gene expression of many times as much B-cell lymphoma 2 (Bcl-2), stromal cell-derived factor-1alpha (SDF-1α), proliferating cell nuclear antigen (PCNA) and vascular endothelial growth factor (VEGF). Furthermore, the SNAP-loaded hydrogel showed continuous cell-proliferating activity for six days, due to the slow release of NO from the hydrogel. Wound-healing studies of rabbits with induced diabetes showed that the application of SNAP-preconditioned BMSCs and NO-releasing hydrogels significantly sped up the healing process, compared to the control group. The wound-healing potential of BMSCs plus NO-releasing hydrogel was further validated by improved collagen deposition and epithelial layer formation, as confirmed by histopathological examination, as well as upregulation of VEGF and SDF-1α biomarkers, as evidenced by gene-expression analysis. These results demonstrated that the application of BMSCs with NO-releasing hydrogel can promote faster regeneration of damaged tissues. Therefore, BMSCs plus NO-releasing hydrogels can be very useful for the treatment of diabetic wounds.Keywords
Funding Information
- Qatar National Research Fund (NPRP12S-0310-190276)
This publication has 72 references indexed in Scilit:
- Stromal cell derived factor-1alpha protects stem cell derived insulin-producing cells from glucotoxicity under high glucose conditions in-vitro and ameliorates drug induced diabetes in ratsJournal of Translational Medicine, 2013
- Pre-conditioned mesenchymal stem cells ameliorate renal ischemic injury in rats by augmented survival and engraftmentJournal of Translational Medicine, 2012
- Systematic review and mixed treatment comparison: dressings to heal diabetic foot ulcersDiabetologia, 2012
- The NO cascade, eNOS location, and microvascular permeabilityCardiovascular Research, 2010
- Vascular endothelial growth factors and vascular permeabilityCardiovascular Research, 2010
- The Role of Vascular Endothelial Growth Factor in Wound HealingJournal of Surgical Research, 2009
- Nitric oxide donor up‐regulation of SDF1/CXCR4 and Ang1/Tie2 promotes neuroblast cell migration after strokeJournal of Neuroscience Research, 2008
- The chemical biology of nitric oxide: Implications in cellular signalingFree Radical Biology and Medicine, 2008
- Stromal cell–derived factor 1 promotes angiogenesis via a heme oxygenase 1–dependent mechanismJournal of Experimental Medicine, 2007
- Nitric oxide: a newly discovered function on wound healingActa Pharmacologica Sinica, 2005